i2Vision
Promoting Therapeutic Advances with Robust Medical Content

Great medical content is a catalyst for pharmaceutical companies to promote novel therapeutic products and create brand awareness. Their perennial need is to develop compelling content at each stage of the clinical development journey, which must be compliant with evolving regulatory guidelines.

i2Vision is a full-service, strategic marketing agency, championing unmatched expertise in delivering innovative solutions for product promotion. Its marketing and communication experts with diverse skill sets and industry knowledge create scientifically vetted content that complies with industry regulations. It has a keen focus on ophthalmology, among a broad array of healthcare specialities.

At the heart of i2Vision is a group of leading ophthalmologists—i2 visionaries—serving as key opinion leader (KOL) advisors who play a critical role in providing valuable insights and feedback from a clinical standpoint. This enables i2Vision to articulate factually accurate content on clinical development, which is well-aligned with market expectations.

“Our deep understanding of commercialization from publication and stakeholder engagements to market access, patient acquisition and retention make us a valuable resource for our clients to better market their ophthalmic brands,” says Matt Swanson, CEO and principal of i2Vision. i2 offers a comprehensive suite of planning and insight discovery services including KOL engagement for campaign development, medical writing, media planning, and events coordination to promote the latest scientific advancements in the field of ophthalmology.

i2Vision’s team of medical writers follows a proactive approach in catering to specific therapeutic areas and target audiences. The strategic planning starts with the discovery phase, where they conduct market research and opportunity assessment. This allows i2Vision to comprehend clients’ key strategic imperatives to formulate an impactful communication campaign, showcasing the core narrative in an ever evolving marketplace.

Its extensive marketing knowledge in ophthalmic care enables the team to produce documentation for all phases of clinical development and concisely present the technical and scientific information. The experts create bonafide content while taking advantage of conventional, proven marketing tactics to ensure maximum visibility. It is then strategically amplified in every media platform to build up constructive perception.

What differentiates i2Vision is its white-glove service in delivering well-structured scientific documents. Its strong relationship with industry leaders, along with a commitment to data-driven precision, enables it to provide efficient medical communication services.

Substantiating their efficacy is an instance where a client needed to shift a physician segment’s opinions on causality rights for a specific disease state. Establishing consensus among key thought leaders was deemed essential for them to support their product as a better treatment option.

i2Vision assembled a delphi panel of experts to discuss the regime and establish consensus on treatment approach through literature review, multiple surveys, and meetings. It published a series of articles in relevant journals. The campaign functionally changed the mindset among practicing physicians about that particular disease and received positive responses from the community.

Building on its agile and adaptive approach to meeting clients’ requirements and proficiency in commercialization, i2Vision has launched more than 40 brands, nationally and globally. Deploying i2Vision as their specialty marketing partner, pharmaceutical brands can rest assured that their medical content is authentic and compliant.